John D. Quisel, EVP, Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 7,168 shares at $45.23 ($324K) on 2019-09-10, disclosed to the SEC on 2019-09-10.
Seasonal sale ($324k) by EVP, Chief Business Officer — this insider has traded XLRN in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.23 | 3,584 | $162K | 50.0% |
| 2 | $45.23 | 3,584 | $162K | 50.0% |
| Total | $45.23 avg | 7,168 | $324K | 100% |
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |